Challenge to WARF hESC Patents Cites Recent U.S. Supreme Court Decision
By Dr. Matthew Watson
are being challenged in a new legal filing that cites the recent U.S.
Supreme Court decision that barred the patenting of human genes.
Wisconsin Alumni Research Foundation (WARF), which holds the patents on the
much-heralded work performed by Jamie Thomson at the University of Wisconsin. The lawsuit was filed
by the Public Patent Foundation of New York City on behalf of
Consumer Watchdog, a nonprofit group in Santa Monica, Ca. Jeanne
Loring, director of the Center for Regenerative Medicine at the
Scripps Research Institute, is also involved along with Alan
Trounson, president of the California stem cell agency. The agency
itself is not a party.
so-called Myriad decision last month by the nation's highest court which said,
“Myriad did not create anything. To
be sure, it found an important and useful gene, but separating that
gene from its surrounding genetic material is not an act of
invention.”
"WARF did not create or alter the
properties inherent in stem cells any more than Myriad created or
altered the genetic information encoded in the DNA it claimed.”
an earlier decision by the U.S. Patent Office. The Public Patent
Foundation, which was a successful party in the Myriad case, did the earlier legal work on the challenge to the WARF patents as well as this
week's appeal.
said the WARF patents have "put a severe burden on taxpayer-funded
research in California.”
“We don't want to do anything that
gets in the way of finding treatments for some of the biggest killers
today, so we feel that all patients with all kinds of diseases
deserve to have access to these kinds of cells.”
"Human embryonic stem cells hold
great promise for advancing human health, and no one has the ethical
right to own them.”
said,
“The best course if WARF truly
cares about scientific advancement would be to
simply abandon these over-reaching patent claims.”
Diego U-T cited intellectual property attorney Lisa Haile of DLA
Piper as saying,
“A successful use of the Myriad case
as a precedent for throwing out the foundation’s patent would open
the door to similar challenges in just about any biotech product
using material derived from life.”
WARF made no immediate comment.
appeared in the Milwaukee Journal, Genomeweb and the LaCross Tribune.
California Legislation, Human Egg Sales and Profits
By Dr. Matthew Watson
California legislation to allow women
to be paid for their eggs for scientific research is sailing toward
final passage literally swaddled in motherhood and apple pie
arguments. Missing from the debate is a key reason behind
the bill – building profits for what some call the “baby
business.”
The legislation is touted as providing
equal treatment for women, permitting them to be paid for supplying
eggs for stem cell and other research, much as men are paid for
sperm. It also would put women who sell their eggs for research on an
equal economic footing with women who sell their eggs for fertility
treatments, which is currently permitted under state law. Payments to
those women range from an average of $9,000 to as much as $50,000,
according to a legislative analysis of the bill.
Assemblywoman Susan Bonillla,
D-Concord, author of the bill(AB926), says,
“It is time to let women, just as any
other research subject, make an informed decision as to
participation, and justly compensate them for doing so.”
has had serious impact on fertility research. In a legislative bill analysis, she says,
“It has led to a de facto prohibition
on women’s reproductive research in California, adversely
impacting the same women that the ban intended to protect. With few
oocytes donated, fertility research and fertility preservation
research has been at a standstill. This greatly affects women
suffering from fertility issues and women facing cancer who would
like to preserve their oocytes.”
behalf of an industry group, the American Society for Reproductive Medicine of Alabama. The fertility or baby business, which is largely
unregulated, brings in about $5 billion annually in the United
States from something like 500 clinics. It has grown rapidly over the
last couple of decades, but is likely heading for a soft spot.
on the Internet discussing the industry's economic challenges.
However, demographic studies show that the size of the key market
for fertility services is stagnating. A 2012 report by the federal
government projects that the number of women in the 35 to 44 age
group, prime consumers of fertility services, is likely to grow only
0.5 percent from 2010 to 2020. And since that forecast was made, the
Census Bureau has downgraded its projections for total population
growth.
a new, potential revenue stream for the industry. Fertility clinics
would be able to buy the eggs and then resell them to researchers,
adding premiums for eggs from women with special characteristics. The bill would also add a tool for bringing down the cost of fertility
treatments, which can run as much as $12,000 to $17,000 a round or
more and require several rounds, according to the NIH. Clinics could discount those prices for some women, bringing in
new customers, if they agree to authorize the use of excess eggs for
scientific research.
pernicious. What is pernicious is the absence of discussion of the
economics of the legislation. Without a full understanding of all
that is at stake, including economic issues and motivations,
legislators, the governor and the public are hard-pressed to make
good decisions about a significant change in California law.
raised serious questions about the treatment of women by fertility
clinics, noting that the bill would turn egg providers into “vendors”
– not patients of the clinics. The Center for Genetics and Society
in Berkeley has captured the arguments in opposition including
testimony before a Senate committee hearing early in June.
lost a 31-year-old daughter to cancer seven years after the younger
woman sold her eggs three times, told lawmakers,
“Unlike infertile women who are
considered patients, egg donors are treated as vendors( (her italics).
When they walk out of the IVF clinic, no one keeps track of them.
My daughter’s death was not reported. The long-term risks of egg
donation are unknown."
now a physician with a Ph.D. in biology, testified that she wound up
in an intensive care unit after 60 eggs were extracted from her in
2001. She said,
“I fear that cases like mine are
buried deep by fertility centers concerned about their image. An
industry thriving on profits and reputation has little incentive to
report adverse events, or protect the health and medical rights of
donors.”
cell agency on all this? The agency has not taken a position on the
bill nor have any major research organizations. The measure does not
change the law affecting agency-funded research, which bans the use of
compensation for eggs in its research. Enactment of the law, however, would
create a two-tier stem cell research standard in California, one for
scientists not constrained by the payment ban and another for those
who could use the full range of research tools. Some stem cell
researchers may well think that they have become disadvantaged as a
result.
(Editor's note: An earlier version of this article said the IVF business generated $4 billion in revenues annually. More recent estimates place it at $5 billion.)
Stem cell therapy can be done in PH — PMA President
By Sykes24Tracey
Manila, Philippines -- Philippine Medical Association (PMA) President Dr. Leo Olarte said yesterday Filipinos need not go abroad or seek foreign consultation if they want to undergo stem cell therapy to cure an ailment.
Olarte warned of the risks and complications involved in stem cell therapy when improperly administered, citing the case of a government official who complained of feeling weak after the procedure was performed on him by a group of foreign medical team inside a posh hotel in Mandaluyong City.
The PMA chief said there are local experts who are capable of performing safe and reliable stem cell treatments in the country using the patient's own stem cells.
The other day, a lawyer for Dangerous Drugs Board (DDB) Chairman Antonio Villar faced the media and revealed that her client is filing charges against the foreign medical team who performed the procedure on him.
Lawyer Claire Pagayanan said the lead doctor who performed the stem cell therapy was from Germany while the other two doctors and nurses who assisted him were from Thailand.
Villar reportedly paid 15,000 euros or approximately P1.2 million for the procedure.
"Doctors who perform this therapy should be licensed by the Philippine Food and Drugs Administration. Before foreign doctors could perform here, they should apply for a license from the Professional Regulation Commission," he said. Those who fail to do so will be in "clear illegal practice of medicine in violation of the Medical Act of 1959," Olarte added.
For his part, PMA spokesperson Dr. Mike Aragon lamented how colonial mentality has affected the decision-making process of some Filipinos. "Maybe they are not well-informed about stem cell therapy, or it is the colonial mentality. Many of us think that if it is foreign, it is something good," Aragon said.
In the country, the only Department of Health (DoH)-approved stem cells that can be used for treatment are the patient's own stem cells harvested from his or her blood, bone marrow and fat.
Follow this link:
Stem cell therapy can be done in PH — PMA President
Stem-cell therapy wipes out HIV in 2 patients
By LizaAVILA
LONDON - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday.
Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer.
Since the transplants, doctors have been unable to find any evidence of HIV infection, Timothy Henrich of Harvard Medical School and Brigham and Women's Hospital in Boston told an International AIDS Society conference in Kuala Lumpur.
While it is too early to say for sure that the virus has disappeared from their bodies altogether, one patient has now been off antiretroviral drug treatment for 15 weeks and the other for seven weeks.
Last July Henrich first reported that the two men had undetectable levels of HIV in their blood after their stem-cell treatment, but at that time they were still taking medicines to suppress HIV.
Using stem-cell therapy is not seen as a viable option for widespread use, since it is extremely expensive, but the latest cases could open new avenues for fighting the disease, which infects about 34 million people worldwide.
The latest cases resemble that of Timothy Ray Brown, known as "the Berlin patient", who became the first person to be cured of HIV after receiving a bone marrow transplant for leukaemia in 2007. There are, however, important differences.
While Brown's doctor used stem cells from a donor with a rare genetic mutation, known as CCR5 delta 32, which renders people virtually resistant to HIV, the two Boston patients received cells without this mutation.
"Dr. Henrich is charting new territory in HIV eradication research," Kevin Robert Frost, chief executive officer of the Foundation for AIDS Research, which funded the study, said in a statement.
Scientific advances since HIV was first discovered more than 30 years ago mean the virus is no longer a death sentence and the latest antiretroviral AIDS drugs can control the virus for decades.
Here is the original post:
Stem-cell therapy wipes out HIV in 2 patients
Stem Cell Therapy Treatment for DuchenneMuscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By LizaAVILA
Stem Cell Therapy Treatment for DuchenneMuscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for DuchenneMuscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Stair climbing is easy now. 1....
By: neurogenbsi
Here is the original post:
Stem Cell Therapy Treatment for DuchenneMuscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video
PMA Probes Stem Cell Therapy in Hotels – Video
By daniellenierenberg
PMA Probes Stem Cell Therapy in Hotels
Please like the official Facebook page of Philippine Medical Association https://www.facebook.com/PhilippineMedicalAssociation The Philippine Medical Association is calling for a probe into...
By: PhilMedAssociation
Go here to read the rest:
PMA Probes Stem Cell Therapy in Hotels - Video
Stem Cell Therapy Treatment for Distal Peripheral Neuropathy by Dr Alok Sharma, Mumbai, India. – Video
By JoanneRUSSELL25
Stem Cell Therapy Treatment for Distal Peripheral Neuropathy by Dr Alok Sharma, Mumbai, India.
Improvement seen in Gujarat boy just 5 day after Stem Cell Therapy Treatment for Distal Peripheral Neuropathy by Dr Alok Sharma, Mumbai, India. After Stem Ce...
By: neurogenbsi
See more here:
Stem Cell Therapy Treatment for Distal Peripheral Neuropathy by Dr Alok Sharma, Mumbai, India. - Video
Stem Cell Therapy and Regenexx KUSA TV News – Video
By Dr. Matthew Watson
Stem Cell Therapy and Regenexx KUSA TV News
By: Regenexx
Risks and benefits of stem cell therapy – Video
By JoanneRUSSELL25
Risks and benefits of stem cell therapy
Tony Velasquez and Karmina Constantino talk to Philippine Stem Cell Society founding member president of Philippine Academy of Aesthetice Academy Dr. Levi ...
By: ANCalerts
Experience in Stem Cell Therapy – Video
By daniellenierenberg
Experience in Stem Cell Therapy
#3588; #3640; #3603; #3649; #3614; #3607; #3652; #3604; #3657; #3649; #3594; #3619; #3660; #3611; #3619; #3632; #3626; #3610; #3585; #3634; #3619; #3603; #3660; #3649; #3621; #3632; #3612; #3621; #3621; #3633; #3614; #3608; #3660; #3607; #3637; #3656; #3588; #3640; #3603; #3649; #3617; #3656; #3588; #3640; #3603; #3649; #3614; #3607; #3652; #3604; #3657; #3619; #3633; #3610; #3585; #3634; #3619; #3619; #3633; #3585; #3625; #3634; #3650; #3604; #3618; #3585; #3634; #3619; #3593; #3637; #3604; Stem Cell #3651; #3609; #3591; #3634; #3609; "Thailand Innovative Medical Tourism" #3607; #3637; #3656; #3592; #3633; #3604; #3586; #3638; #3657; #3609; #3651; #3609; #3623; #3633; #3609; #3648; #3626; #3634; #3619; #3660; #3607; #3637; #3656; 29 #3617; #3636; #3606;...
By: Pat R
See the rest here:
Experience in Stem Cell Therapy - Video
Stem Cell Therapy Treatment for Head Injury by Dr Alok Sharma, Mumbai, India. – Video
By LizaAVILA
Stem Cell Therapy Treatment for Head Injury by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Head Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1) Sensations all over the body...
By: neurogenbsi
View original post here:
Stem Cell Therapy Treatment for Head Injury by Dr Alok Sharma, Mumbai, India. - Video
Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. – Video
By Dr. Matthew Watson
Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. His neck and...
By: neurogenbsi
Read more from the original source:
Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. - Video
Flax Day 0 Stem cell Therapy 360p – Video
By raymumme
Flax Day 0 Stem cell Therapy 360p
By: WichitaEquineSm
View post:
Flax Day 0 Stem cell Therapy 360p - Video
Giving hope: The promise of stem cell therapy – Video
By Dr. Matthew Watson
Giving hope: The promise of stem cell therapy
MANILA - As stem cell treatment begins to gain traction among Filipinos, a surgeon believes the country is now entering a new phase in medicine.
By: TheABSCBNNews
Read more:
Giving hope: The promise of stem cell therapy - Video
STEM CELL THERAPY discussed in ABS-CBN, UMAGANG KAY GANDA, PUNTO por PUNTO – Video
By LizaAVILA
STEM CELL THERAPY discussed in ABS-CBN, UMAGANG KAY GANDA, PUNTO por PUNTO
Please like the official Facebook page of Philippine Medical Association https://www.facebook.com/PhilippineMedicalAssociation Anthony Taberna discusses Lega...
By: PhilMedAssociation
The rest is here:
STEM CELL THERAPY discussed in ABS-CBN, UMAGANG KAY GANDA, PUNTO por PUNTO - Video
FCT Controversy: MY STEM CELL THERAPY STORY
By Sykes24Tracey
By: Jesus G. Dureza Posted: July 1, 2013 8:28 am
Over the last few days, Fresh Stem Cell Therapy (FCT) got into the headlines due to some controversy involving alleged deaths and complaints mentioning prominent names blaming stem cell treatment for their alleged negative effects.Naturally, just like any controversy, the stories unduly put under cloud this innovative and pioneering science of regenerative medicine that is reputed to treat illnesses, bring well being and rejuvenation.
MY FRIENDS The current news reports caught public attention and went viral. Many friends who were following Beths FCT experience and who were planning to also undergo FCT were calling. They were bothered by the reports. I was myself personally disturbed because all of them who were mentioned as having experienced negative results, I knew in person. Congressman ERICO AUMENTADO of Bohol and Camiguin Congressman LOLOY ROMUALDO both were my close friends and whom I worked with when I was with the government. And the controversy all the more struck me because I and my wife Beth saw and experienced for ourselves the positive NOT NEGATIVE results of FCT seven months after treatment at VILLA MEDICA in Germany.
Let me trace back. I knew Congressman Erico well even when he was still Bohol Governor. His successful efforts in clearing his province of armed insurgency gained national attention. When I was Malacanang Presidential Peace Adviser, I used the Bohol experience as example of a success story. So, when initial reports surfaced about FCT having caused his death, I sat up and took special attention. Later, his son came out publicly DENYING the story saying his father died of pneumonia and NOT due to FCT. He said his fathers lungs were already in serious condition but after getting a first infusion of FCT, his condition suddenly and dramatically improved and he was hitting the election campaign trail like superman. In fact they were preparing to again return to Germany for another infusion encouraged by its initial favorable results when death intervened and overtook events.
The other prominent name mentioned with FCT was former Congressman Loloy. We were together as colleagues in Congress. The Romualdo family had dominated politically the Camiguin island province for a long time up to the present. The circumstances of his undergoing stem cell treatment , however, are not yet clear. My cursory check results showed that he did NOT get FCT from Villa Medica in Germany. This will have to be further validated though.
The other prominent name was former Customs official (and now with Dangerous Drugs Board) ANTONIO BEBOT VILLAR. We were together in the Arroyo administration. He said he and his wife had FCT in a 5-star hotel in Metro Manila, by German and Thai doctors but NOT in Germany. His condition allegedly worsened after the treatment. MY OWN STORY I will not venture to further deal on those incidents simply because they are now subject of further close look by the authorities. And I am not privy with the true facts surrounding their cases. But I will deal on some information that are of my own personal knowledge and the personal experience I and my wife BETH can competently attest to.
As I have written previously, I and my wife Beth traveled all the way to EDENKOBEN, GERMANY last November, 2012 some seven (7) months ago for FCT in the VILLA MEDICA (VM) clinic facilities as an alternative remedy to her deteriorating kidney condition. We were NOT assured that there would be positive results by VM representatives but we took the chance after I made extensive research and consultations with doctors and experts. We even traveled to Bangkok, Thailand to make further inquiries. We were encouraged by reports of well-being and regenerative effects on vital organs. And we took efforts to talk to those who themselves underwent the procedure. We gathered that VILLA MEDICA and its FCT, using fresh stem cell from the fetus of clinically controlled and raised sheep had been recognized, authorized, licensed and closely monitored by stringent standards imposed by GERMAN HEALTH AUTHORITIES of the German government. VILLA MEDICA, founded in 1963 had also a long track record of about 50 YEARS. Fresh cell therapy was pioneered by Dr PAUL NIEHANS in 1931. Another doctor in 1980, GUNTER BIOBEL scientifically dissected the technology and was awarded in 1999 the Nobel Prize in Physiology or Medicine.
After some soul-searching and weighing our options, we decided and took the trouble of traveling to Germany at some cost even when we were told that there were stem cell treatments also being done in the Philippines, at more considerable costs, although still in their infancy stage. We had no way of verifying the reliability of local Philippine FCT providers due to their fairly recent track record. When I checked with St. Lukes Hospital Regenerative division at Global City, the division chief told me they were into this procedure: harvesting human stem cells from the patients themselves, usually from the bone marrow, churn them for 2 weeks in the laboratory using German-made machines and injecting them back to the patient over a 12 month period. However she declined to cite or give an example of a success story simply because they had been into the procedure fairly recently. Also, we were informed that to achieve optimum results, fresh stem cells must be injected (in the buttocks) within two hours from its harvesting from the donor fetus. So getting the FCT infusion right there in the clinic in Germany was far better than having the injectables flown from Germany or elsewhere and get the infusion in Manila, travel time obviously reducing the stem cells efficacy or potency. More importantly, seven months ago, there were NO clear Philippine regulations yet governing FCT, due to its infancy, to give us some level of reasonable comfort and assurance. On the other hand, the procedure in Germany we were told adhered to strictest German standards imposed by the German government. These regulations even cover the growing and maintenance of donor sheep and the harvesting of stem cells from 18-week old fetus under clinical control and conditions. And specific success stories were many.
And more importantly, we were in a desperate mode due to the continuous decline of Beths kidney conditions. As preparatory steps, Beth went through a series of tests which were screened and studied by her doctors in Manila and even through German doctors in Villa Medica in Edenkoben who had to make the final decision whether she was qualified to get the treatment. Even her Nephrologist who happens to be also a family friend and a known kidney transplant surgeon at the National Kidney Institute recommended that we try FCT. That sealed our decision.
So, off we went to Germany last November, 2012. Of course at great expense. (Treatment costs EURO 15,000 or about 830,000 PHP ) But nonetheless. AFTER 7 MONTHS Today, seven months after the treatment, and in contrast to the sketchy stories surrounding the cases of my friends ERICO, LOLOY and BEBOT as reported in the media, our own testimonials of the FCT at VILLA MEDICA are a bit different from those horror stories. I also personally met and discussed with others who themselves went to the German facility for FCT and our testimonials coincided.
View post:
FCT Controversy: MY STEM CELL THERAPY STORY
Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use
By JoanneRUSSELL25
Public release date: 28-Jun-2013 [ | E-mail | Share ]
Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair
Putnam Valley, NY. (June 28 2013) A study carried out in India examining the safety and efficacy of self-donated (autologous), transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M), has found that patients receiving the transplants, when compared to a control group of TD2M patients who did not receive transplantation, required less insulin post-transplantation.
The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct0920bhansali.
"There is growing interest in the scientific community for cellular therapies that use bone marrow-derived cells for the treatment of type 2 diabetes mellitus and its complications," said study corresponding author Anil Bhansali, PhD professor and head of the Endocrinology Department at the Post Graduate Institute of Medical Education in Chandrigarh, India. "But the potential of stem cell therapy for this disease is yet to be fully explored."
While there is growing interest in using stem cell transplantation to treat TD2M, few studies have examined the utility of bone marrow-derived stem cells. By experimenting with bone marrow-derived stem cells, the researchers sought to exploit the rich source of stem cells in bone marrow.
Their study aimed at evaluating the efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with T2DM and who also had good glycemic control. Good glycemic control emerged as an important factor in the transplantation group and in the non-transplanted control group.
Cell transplantation had a significant impact on the patients in this study as those administered cells demonstrated a significant reduction in insulin requirement. A significantly smaller reduction in the insulin requirement of the control group was also observed but a "repeated emphasis on life style modification" was believed to be a contributing factor in this effect.
According to Dr. Bhansali, the strength of their study included the inclusion of a homogenous patient population with T2DM which exhibited good glycemic control, and the presence of a similar control group that did not get cell transplants.
"The efficacy and safety of stem cell therapy needs to be established in a greater number of patients and with a longer duration follow-up," concluded Bhansali and his co-authors. "The data available so far from animal and human studies is encouraging, however, it has enormous limitations."
Read the original:
Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use
‘Bebot’ Villar: Stem cell therapy made me weaker – Video
By NEVAGiles23
#39;Bebot #39; Villar: Stem cell therapy made me weaker
MANILA, Philippines - A government official on Thursday said he is no believer in stem cell therapy after undergoing the procedure but getting zero health be...
By: TheABSCBNNews
Go here to see the original:
'Bebot' Villar: Stem cell therapy made me weaker - Video
FDA urges hotels to guard vs stem cell therapy
By Sykes24Tracey
By: Jet Villa, InterAksyon.com June 29, 2013 6:55 PM
A scientist working on stem cells in a laboratory. AGENCE FRANCE-PRESSE
InterAksyon.com The online news portal of TV5
MANILA, Philippines -- The Food and Drug Administration has asked hotels to guard against allowing stem cell therapy to be performed in their premises.
FDA acting director Dr. Kenneth Hartigan-Go said hotels may be held liable for guests found performing or undergoing stem cell therapy in their rooms.
Go pointed out that performing medical procedures like stem cell therapy in a non-health facility is illegal.
Under Republic Act 9711 or the Food and Drug Administration Act of 2009, violators face a fine of up to P500,000 plus closure of the establishment and jail terms.
In FDA Advisory 2013-012 issued May 15, the agency warned the pubic against "receiving unapproved stem cell preparations in non-health facilities."
"Patients who might receive stem cell preparations and therapy without prior FDA-Department of Health approval run the risks of contracting infectious diseases and severe complications which may lead to permanent disabilities, physical deformities, serious iatrogenic harm, autoimmune diseases and worst death, and without the benefit of health insurance coverage," the advisory said.
Visit link:
FDA urges hotels to guard vs stem cell therapy
Gov’t to tighten rules on stem cell therapy
By Sykes24Tracey
By Michael Lim Ubac Philippine Daily Inquirer
Hospitals offering stem cell therapy have until Aug. 31 to seek or renew their accreditation from the Department of Health (DOH), a Palace official said Friday.
For the information of the public, the DOH is accrediting hospitals for this kind of treatment, and come Aug. 31, these hospitals should file their accreditation requirements (with DOH) for them to continue to offer this treatment, said deputy presidential spokesperson Abigail Valte.
The government is eyeing stricter regulation of hospitals offering stem cell therapy amid speculations that the recent deaths of three politicians were due to the xenogenic (animal-based stem cell) treatment they had received in Germany last year.
Dr. Leo Olarte, president of the Philippine Medical Association (PMA) and spokesperson of the Philippine Society for Stem Cell Medicine, said the groups were still trying to determine whether the politicians had died due to their illness or due to hypersensitivity reaction from the xenogenic stem cells.
Last week, the PMA also warned of a possible scam involving German doctors coming over to perform stem cell therapy on patients in five-star hotels at around P1 million per shot.
Valte echoed a similar warning from the DOH against doctors offering the procedure in their clinics, saying that hospitals, not (individual) doctors, nor stand-alone clinics, are the ones being accredited.
Not a cure all
The Palace official also cautioned the public against claims that stem cell therapy was a cure all (for diseases).
There is no treatment that will cure all of your ills. Much less your love problems, Valte said.
Read more from the original source:
Gov’t to tighten rules on stem cell therapy